Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01067742 · ClinicalTrials.gov registry record

The Natural History of Mucolipidosis Type IV

A clinical trial, sponsored by Baylor Research Institute.

Terminated
Registry status
7
Enrollment target

NCT01067742: Clinical Trial study, sponsored by Baylor Research Institute.

NCT01067742 is a clinical trial that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01067742 was terminated before completion, sponsored by Baylor Research Institute.

TERMINATED
Registry status
7 participants
Enrollment target

Study Summary

The purpose of this study is to define the natural history of Mucolipidosis Type IV and identify potential clinical outcome measures.

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2009-02-19
Est. Completion 2021-07-07
Baylor Research Institute

180 total trials

Why NCT01067742 stopped before completion

NCT01067742 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01067742 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01067742 about?

NCT01067742 is a clinical study titled "The Natural History of Mucolipidosis Type IV". The purpose of this study is to define the natural history of Mucolipidosis Type IV and identify potential clinical outcome measures.

What is the current status of trial NCT01067742?

This trial is currently terminated. The enrollment target is 7 participants. The study started on 2009-02-19. Estimated completion is 2021-07-07.

Who is sponsoring clinical trial NCT01067742?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01067742, the US trial registry maintained by the National Library of Medicine. NCT01067742 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.